Trials / Conditions / Radiographic Contrast Agent Nephropathy

Radiographic Contrast Agent Nephropathy

13 registered clinical trials studyying Radiographic Contrast Agent Nephropathy.

Status	Trial	Sponsor	Phase
Unknown	Relationship Between ALDH2 and CIN NCT02643706	Qilu Hospital of Shandong University	—
Completed	NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial NCT02483143	Karadeniz Technical University	Phase 4
Completed	The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI NCT01866800	Tel-Aviv Sourasky Medical Center	Phase 4
Unknown	N-Acetyl Cystein and Contrast Nephropathy NCT01820195	Imam Khomeini Hospital	Phase 3
Terminated	Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) NCT01168024	Osprey Medical, Inc	N/A
Terminated	Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy NCT01654328	Prof. Dr. J. Wetzels	N/A
Unknown	RenalGuard System for Prevention of Contrast Induced Nephropathy NCT02029820	Hospital Sao Lucas da PUCRS	Phase 3
Completed	Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy NCT01525888	Soroka University Medical Center	N/A
Unknown	Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System NCT01778140	Taipei Medical University	N/A
Completed	Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy NCT02137863	TC Erciyes University	Phase 4
Unknown	Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP NCT00584350	Université de Sherbrooke	Phase 4
Completed	Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate NCT00540904	Barretos Cancer Hospital	Phase 2
Completed	Does Bicarbonate in Addition to Theophylline Reduce CIN? NCT02643602	Technical University of Munich	N/A